Mozley PD - Search Results

1

Logistic discriminant parametric mapping: a novel method for the pixel-based differential diagnosis of Parkinson's disease.

Acton PD, Mozley PD, Kung HF. Acton PD, et al. Among authors: mozley pd. Eur J Nucl Med. 1999 Nov;26(11):1413-23. doi: 10.1007/s002590050473. Eur J Nucl Med. 1999. PMID: 10552082

2

Biodistribution and imaging with (123)I-ADAM: a serotonin transporter imaging agent.

Newberg AB, Plössl K, Mozley PD, Stubbs JB, Wintering N, Udeshi M, Alavi A, Kauppinen T, Kung HF. Newberg AB, et al. Among authors: mozley pd. J Nucl Med. 2004 May;45(5):834-41. J Nucl Med. 2004. PMID: 15136634 Free article.

3

Differences in [99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease.

Swanson RL, Newberg AB, Acton PD, Siderowf A, Wintering N, Alavi A, Mozley PD, Plossl K, Udeshi M, Hurtig H. Swanson RL, et al. Among authors: mozley pd. Eur J Nucl Med Mol Imaging. 2005 Mar;32(3):302-7. doi: 10.1007/s00259-004-1667-x. Epub 2004 Oct 2. Eur J Nucl Med Mol Imaging. 2005. PMID: 15791439 Clinical Trial.

4

Comparison of region-of-interest analysis and human observers in the diagnosis of Parkinson's disease using [99mTc]TRODAT-1 and SPECT.

Acton PD, Newberg A, Plössl K, Mozley PD. Acton PD, et al. Among authors: mozley pd. Phys Med Biol. 2006 Feb 7;51(3):575-85. doi: 10.1088/0031-9155/51/3/007. Epub 2006 Jan 11. Phys Med Biol. 2006. PMID: 16424582

5

The dosimetry of iodine-123-labeled TISCH: a SPECT imaging agent for the D1 dopamine receptor.

Mozley PD, Zhu X, Kung HF, Selikson MH, Hickey J, Galloway S, Pfieffer N, Alavi A. Mozley PD, et al. J Nucl Med. 1993 Feb;34(2):208-13. J Nucl Med. 1993. PMID: 8429338 Free article.

6

Dosimetry of an iodine-123-labeled tropane to image dopamine transporters.

Mozley PD, Stubbs JB, Kim HJ, McElgin W, Kung MP, Meegalla S, Kung HF. Mozley PD, et al. J Nucl Med. 1996 Jan;37(1):151-9. J Nucl Med. 1996. PMID: 8543985 Free article.

7

Iodine-123-IPT SPECT imaging of CNS dopamine transporters: nonlinear effects of normal aging on striatal uptake values.

Mozley PD, Kim HJ, Gur RC, Tatsch K, Muenz LR, McElgin WT, Kung MP, Mu M, Myers AM, Kung HF. Mozley PD, et al. J Nucl Med. 1996 Dec;37(12):1965-70. J Nucl Med. 1996. PMID: 8970515 Free article.

8

Synthesis and characterization of technetium-99m-labeled tropanes as dopamine transporter-imaging agents.

Meegalla SK, Plössl K, Kung MP, Chumpradit S, Stevenson DA, Kushner SA, McElgin WT, Mozley PD, Kung HF. Meegalla SK, et al. Among authors: mozley pd. J Med Chem. 1997 Jan 3;40(1):9-17. doi: 10.1021/jm960532j. J Med Chem. 1997. PMID: 9016323

9

Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography.

Tatsch K, Schwarz J, Mozley PD, Linke R, Pogarell O, Oertel WH, Fieber RS, Hahn K, Kung HF. Tatsch K, et al. Among authors: mozley pd. Eur J Nucl Med. 1997 Apr;24(4):415-21. doi: 10.1007/BF00881814. Eur J Nucl Med. 1997. PMID: 9096093

10

Biodistribution and dosimetry of TRODAT-1: a technetium-99m tropane for imaging dopamine transporters.

Mozley PD, Stubbs JB, Plössl K, Dresel SH, Barraclough ED, Alavi A, Araujo LI, Kung HF. Mozley PD, et al. J Nucl Med. 1998 Dec;39(12):2069-76. J Nucl Med. 1998. PMID: 9867143 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

125 results

Search Page

Filters